The researchers typically focus on cancer research but are instead using their expertise to better understand SARS-CoV-2, the virus that causes COVID-19. The winning projects include a variety of research topics related to COVID-19 and SARS-CoV-2, including potential treatments, genetic or immune determinants, and testing.

The foundation drew funds from supporters of its Pershing Square Cancer Research Alliance, which ordinarily provides cancer research funding. The foundation noted it will not stop supporting cancer research but also recognized an opportunity to leverage the expertise of cancer experts in immunotherapy/immunology, genetics, and epigenetics for SARS-CoV-2 research.

The winning academics come from 10 institutions, including seven located in New York state:

1. Cold Spring Harbor Laboratory: Mikala Egeblad, PhD; Dr. David Tuveson, PhD; Dr. Tobias Janowitz, PhD
2. Columbia University: Dr. Adolfo Ferrando, PhD
3. Harvard University: Carla Kim, PhD
4. Icahn School of Medicine at Mount Sinai: Dr. Nina Bhardwaj, PhD; Dr. Eirini Papapetrou, PhD; Arvin Dar, PhD
5. Memorial Sloan Kettering Cancer Center: Benjamin Greenbaum, PhD; Dr. Matthew Hellmann; Dr. Jedd Wolchok, PhD; Dr. Christine Mayr, PhD; Dr. Santosha Vardhana, PhD; Dr. Omar Abdel-Wahab
6. New York University: Dafna Bar-Sagi, PhD; Jef Boeke, PhD; Liam Holt, PhD; Agnel Sfeir, PhD
7. The Rockefeller University: Ali Brivanlou, PhD; Daniel Mucida, PhD; Dr. Sohail Tavazoie, PhD
8. Stanford University: Dr. Howard Chang, PhD
9. Weill Cornell Medicine: John Blenis, PhD; Lewis Cantley, PhD; Christopher Mason, PhD
10. Whitehead Institute for Biomedical Research: Silvia Rouskin, PhD

Pershing Square Foundation aims to provide support for biological discoveries that might not otherwise receive funding, the organization noted. The winning proposals had to meet the foundation's criteria for rigorous scientific research that explores risky or early-stage projects that could result in innovation.

Li-Cor supports virology research for COVID-19
Li-Cor Biosciences offers research solutions for therapeutics development and western blotting. Now, the company is offering researchers a special Odyssey...

Anixa, OntoChem screen SARS-CoV-2 main protease inhibitors
Anixa Biosciences and OntoChem have completed in silico screening of four compounds that could function as SARS-CoV-2 main protease inhibitors.

CSL Behring begins phase II study of COVID-19 therapy
CSL Behring has enrolled the first patient in its phase clinical II study to assess the safety and efficacy of CSL312 (garadacimab, factor XIIa-inhibitory...

Sloan Kettering, Hackensack form immunology collaboration
Memorial Sloan Kettering and Hackensack Meridian Health have formed an immunology research collaboration to support cancer immunotherapy research.

Gates Foundation directs $1.6B to Gavi, the Vaccine Alliance
The Bill and Melinda Gates Foundation announced a five-year, $1.6 billion U.S. commitment to Gavi, the Vaccine Alliance, to deliver vaccines to developing...